Use of pharmaceutical formulation comprising matrix e.g. polysaccharides cellulose and dextran, with protein adsorptive properties, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities

Use of pharmaceutical formulation comprising matrix e.g. polysaccharides cellulose and dextran, with protein adsorptive properties, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities

Use of pharmaceutical formulation comprising a matrix with protein adsorptive properties that can adhere to volatile impurities, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities, is claimed, where the formulation is suitable for intranasal app...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: LIEDTKE, RAINER K
Format: Patent
Sprache:eng ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Use of pharmaceutical formulation comprising a matrix with protein adsorptive properties that can adhere to volatile impurities, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities, is claimed, where the formulation is suitable for intranasal application, and as a barrier for preventing or reducing systemic absorption of impurities in the body. ACTIVITY : Antiallergic; Antiasthmatic; Antimicrobial; Antidote. MECHANISM OF ACTION : None given. Die Erfindung beschreibt die Verwendung intranasaler pharmazeutischer Formulierungen mit proteinadhäsiver Matrix zur Expositions-Prophylaxe gegenüber volatilen allergenen, infektiösen oder toxischen Fremdstoffen.